| CAD | Coronary artery disease |
| CVD | Cardiovascular diseases |
| MCI | Myocardial infarction |
| AMI | Acute myocardial infarction |
| CVDs | Cardiovascular disorders |
| HDL | High-density lipoprotein |
| ECs | Endothelial cells |
| NFI-A | Nuclear factor I-A |
| MCP-1 | Monocyte chemoattractant protein-1 |
| FLT-1 | Fms-related receptor tyrosine kinase 1 |
| HUVECs | Human umbilical vein endothelial cells |
| VCAM-1 | Vascular cell adhesion molecule 1 |
| OGT | O-GlcNAc transferase |
| VR | Ventricular remodeling |
| DCM- | Dilated cardiomyopathy |
| hAVICs | Human calcific aortic valves |
| VSMC | Vascular smooth muscle cell |
| ECs | Endothelial cells |
| RasGAP | Ras GTPase-activating protein |
| HCM | Hypertrophic cardiomyopathy |
| ROS | Reactive oxygen species |
| MMPs | Matrix metalloproteinase |
| IFN-γ | Interferon-γ |
| TNF-α | Tumor necrosis factor |
| VP | Vulnerable plaques |
| STEMI | ST-segment-elevation myocardial infarction |
| LOX | Lysyl oxidase |
| DGCR8 | DiGeorge syndrome critical region 8 |
| ICAM-1 | Intercellular adhesion molecule 1 |
| eNOS | Endothelial nitric oxide synthase 3 |
| MAPK | Mitogen-activated protein kinase |
| C/EBP | CCAAT-enhancer-binding proteins α and β |
| CHF- | Congestive heart failure |